COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 1 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,931,606 | +9.2% | 310,139 | +5.0% | 0.00% | 0.0% |
| Q2 2023 | $6,349,693 | -7.8% | 295,472 | +2.9% | 0.00% | 0.0% |
| Q1 2023 | $6,885,729 | +17.1% | 287,025 | +13.2% | 0.00% | 0.0% |
| Q4 2022 | $5,882,151 | +47.2% | 253,541 | +1.6% | 0.00% | +100.0% |
| Q3 2022 | $3,997,000 | -7.0% | 249,476 | +2.9% | 0.00% | 0.0% |
| Q2 2022 | $4,298,000 | -15.9% | 242,529 | -3.4% | 0.00% | -50.0% |
| Q1 2022 | $5,112,000 | +3.2% | 251,038 | -5.3% | 0.00% | +100.0% |
| Q4 2021 | $4,953,000 | -15.6% | 265,130 | -10.8% | 0.00% | -50.0% |
| Q3 2021 | $5,868,000 | -16.0% | 297,226 | +0.6% | 0.00% | 0.0% |
| Q2 2021 | $6,985,000 | +25.3% | 295,455 | +25.6% | 0.00% | 0.0% |
| Q1 2021 | $5,574,000 | +22.5% | 235,161 | +3.5% | 0.00% | 0.0% |
| Q4 2020 | $4,550,000 | -3.4% | 227,139 | +0.4% | 0.00% | 0.0% |
| Q3 2020 | $4,711,000 | +213.0% | 226,241 | +163.2% | 0.00% | +100.0% |
| Q2 2020 | $1,505,000 | +13.8% | 85,955 | +6.1% | 0.00% | 0.0% |
| Q1 2020 | $1,323,000 | -54.6% | 80,986 | -42.7% | 0.00% | -50.0% |
| Q4 2019 | $2,911,000 | +16.4% | 141,434 | -35.1% | 0.00% | +100.0% |
| Q3 2019 | $2,501,000 | -12.7% | 217,798 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $2,865,000 | +12.7% | 217,798 | +29.7% | 0.00% | 0.0% |
| Q1 2019 | $2,543,000 | -10.5% | 167,938 | +1.5% | 0.00% | 0.0% |
| Q4 2018 | $2,841,000 | -6.9% | 165,408 | -20.0% | 0.00% | 0.0% |
| Q3 2018 | $3,050,000 | -17.7% | 206,863 | +33.1% | 0.00% | -33.3% |
| Q2 2018 | $3,706,000 | +183.6% | 155,374 | +203.9% | 0.00% | +200.0% |
| Q1 2018 | $1,307,000 | +38.5% | 51,119 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $944,000 | +99.6% | 51,119 | +13.5% | 0.00% | – |
| Q3 2017 | $473,000 | -16.1% | 45,036 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $564,000 | +24.2% | 45,036 | 0.0% | 0.00% | – |
| Q1 2017 | $454,000 | -35.3% | 45,036 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $702,000 | +70.8% | 45,036 | +111.1% | 0.00% | – |
| Q3 2016 | $411,000 | +62.5% | 21,336 | 0.0% | 0.00% | – |
| Q2 2016 | $253,000 | +5.0% | 21,336 | +144.2% | 0.00% | – |
| Q4 2015 | $241,000 | – | 8,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |